Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Date: February 19, 2021
Attention: Primary Care Providers
Effective Date: March 15, 2021Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.Call to action: Texas Children’s Health Plan (TCHP) would like to inform network providers that beginning March 15, 2021 Texas Medicaid will change the preferred drug list (PDL) prior authorization criteria for the “Macrolides (oral)” PDL class. The new exception will allow FDA-indicated shorter treatment duration with certain preferred products (such as azithromycin) before approval of a non-preferred option.
How this impacts providers: Currently, the PDL criteria document asks:
Has the client failed a 7-day treatment trial with at least one preferred agent in the last 180 days?
The revised version will change to:
Has the client failed a 7-day treatment trial with at least one preferred agent in the last 180 days? (Exception may apply when a preferred drug requires less than a 7-day treatment trial)
